This cross-sectional, case-control study protocol was approved by the institutional review board of the Catholic University of Korea, Seoul, Korea. The study design followed the tenets of the Declaration of Helsinki for biomedical research. Individuals meeting the eligibility criteria were enrolled between August 2013 and October 2013 in the Department of Ophthalmology, St. Mary's Hospital, Seoul, Korea.
Inclusion criteria for all patients included a best-corrected visual acuity of 20/40 or better, refractive error of greater than −7 spherical diopters (D), a 2 D cylinder, open angle on gonioscopy, and a transparent ocular medium (nuclear color or opalescence, cortical, or posterior subcapsular lens opacity < 1) according to the Lens Opacities Classification System III.
17 Exclusion criteria included a history of ocular trauma, intraocular surgery, systemic, or ocular conditions other than glaucoma known to affect the optic nerve structure, and consistently unreliable visual fields.
Each patient had undergone comprehensive ophthalmic examinations, including a best-corrected visual acuity test, slit-lamp biomicroscopy, IOP measurement by Goldmann applanation tonometry, gonioscopy, central corneal thickness measurements using ultrasonic pachymetry (SP-3000; Tomey Corp., Nagoya, Japan), and dilated fundoscopic examination. Stereoscopic optic disc photography and monoscopic red-free digital fundus photography (Canon Cf-60 UW with Canon EOS D-6 CCD camera; Canon, Tokyo, Japan) were performed. Standard automated perimetry (SAP) was performed using a Humphrey field analyzer (Carl Zeiss Meditec, Dublin, CA, USA), applying the Swedish interactive threshold algorithm (SITA) standard and program 24-2 test. A reliable test was defined as less than 30% fixation losses, false-positives, or false-negatives. The visual field indices, expressed as the mean deviation (MD) and the pattern standard deviation (PSD), were also evaluated. A visual field was defined as a glaucomatous visual field defect if repeatable SAP results revealed a cluster of three or more points that were lower than a 5% probability level or a cluster of two or more points that were lower than a 1% probability level, PSD with a 5% probability level or lower, or glaucoma hemifield test outside normal limits.
Primary open-angle glaucoma was defined as the presence of a glaucomatous optic disc (diffuse, focal thinning of the neuroretinal rim, or notching), an untreated IOP greater than 21 mm Hg, and an associated glaucomatous visual field defect without ocular disease or conditions that may elevate the IOP. Patients were defined as having normal tension glaucoma (NTG) if they had an abnormal glaucomatous optic disc, a glaucomatous visual field defect, and IOP less than or equal to 21 mm Hg during the repeated measurements taken on different days. The healthy control group was defined as those having normal anterior and posterior segments, an IOP less than or equal to 21 mm Hg with no history of increased IOP, an absence of glaucomatous disc appearance (i.e., intact neuroretinal rim without pallor of the optic disc, peripapillary hemorrhages), and no visible RNFL defect according to red-free photography, with no abnormality on SAP.
We divided the glaucoma patients into three stages of glaucoma progression depending on their MD score, as defined by Anderson and Patella's classification: the early stage (MD ≥ −6 dB), the moderate stage (−12 dB ≤ MD < −6 dB), and the advanced stage (MD < −12 dB).
18